GlassScriptPhysician profile
Sheldon L Sebastian
NPI 1679612683
$3,499.26
in general payments reported to CMS, 2019-2025
24 companies · $413 in 2025
The $413 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $671 · 2020: $369 · 2021: $283 · 2022: $512 · 2023: $672 · 2024: $579 · 2025: $413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,456 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,455.84 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $208.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,001.91 | 2019-2025 | Rinvoq, Skyrizi |
| Novartis Pharmaceuticals Corporation | $424.74 | 2019-2024 | |
| Lilly USA, LLC | $282.28 | 2021-2025 | Ebglyss |
| Regeneron Healthcare Solutions, INC. | $239.00 | 2019-2023 | Libtayo |
| Sun Pharmaceutical Industries INC. | $210.82 | 2020-2025 | Ilumya |
| Pfizer INC. | $165.29 | 2019-2023 | |
| Allergan, INC. | $148.08 | 2020-2022 | |
| Celgene Corporation | $121.55 | 2019 | |
| Arcutis Biotherapeutics, INC. | $110.71 | 2024 | Zoryve |
| Incyte Corporation | $105.93 | 2025 | Opzelura |
| Stemline Therapeutics INC. | $104.87 | 2021 | |
| Dermavant Sciences, INC. | $93.90 | 2024 | Vtama |
| Galderma Laboratories, L.P. | $89.66 | 2019 | |
| Almirall LLC | $85.74 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $78.51 | 2025 | Sotyktu |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $64.18 | 2024-2025 | Adbry |
| Ucb, INC. | $53.69 | 2023 | |
| Organogenesis INC. | $40.67 | 2020-2023 | Puraply |
| Sanara Medtech INC. | $17.39 | 2024 | Celleraterx |
| Vyne Pharmaceuticals INC. | $14.63 | 2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.39 | 2020 | |
| Janssen Biotech, INC. | $13.06 | 2020 | |
| Genentech USA, INC. | $11.06 | 2019 | |
| Organon LLC | $7.20 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheldon Sebastian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.